In clinical trials, cyclical administration in AFP (nAFP or rhAFP) and AFPR vaccines causes dysfunction of MDSCs, intensification of immune response, tumor destruction and prolongation of life [5,10,52,53]. Here, AFP is linked to neoplasm.